TotalMarketCap

GSK

GSKNYSE United KingdomHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$95.128 B

$47.03 -0.32%

Close of 5 Oct 2026

As of 5 Oct 2026, GSK (GSK) has a market capitalization of $95.1B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

4,315,445,026

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →
  1. #11Bristol Myers SquibbBMY$124.9B
  2. #12SanofiSNY$97.4B
  3. #13GSKGSK$95.1B
  4. #14Regeneron PharmaceuticalsREGN$75.7B
  5. #15Takeda PharmaceuticalTAK$56.4B

What if GSK were worth as much as…

Open the what-if tool →

Gold $28.7T

$14,193.43

Per share 302× higher

Bitcoin $1.72T

$850.64

Per share 18.1× higher

Nvidia $5.64T

$2,787.45

Per share 59.3× higher

Or at a round number

$200.0B$500.0B$1.00T$2.00T

Where these numbers come from

Share counts and financials for GSK are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 6 Oct 2026. Read the methodology.